Citations

Showing 10 of 108104 citations.

In‐hospital opioid consumption, but not pain intensity scores, predicts 6‐month levels of pain catastrophizing following hepatic resection: A trajectory analysis
Pagé, M. Gabrielle , Karanicolas, Paul J. , Wei, Alice C. , McHardy, Paul , Ladak, Salima , Ayach, Nour, Sawyer, Jason , McCluskey, Stuart A. , Srinivas, Coimbatore, Katz, Joel , Coburn, Natalie G. , Hallet, Julie , Law, Calvin , Greig, Paul D., Clarke, Hance , Cleary, Sean, Cleary, Sean P.

Mayo Clinic

European Journal of Pain | October 9, 2018 | Volume: 23 | Issue: 3 | Pages: 503-514

10.1002/ejp.1324 | PMID 30298685 Get It

AbstractBackgroundThe study aims were to model acute pain intensity and opioid consumption trajectories up to 72 hr after open hepatic resection, identify predictors of trajectory membership and examine the association between trajectory memberships and 6‐month pain and psychological outcomes. This is a long‐term analysis of a published randomized controlled trial on the impact of medial open transversus abdominis plane catheters on post‐operative outcomes.MethodsA total of 152 patients (89 males; mean age 63.0 [range: 54–72]) completed questionnaires on pain and related characteristics pre‐operatively and 6 months post‐operatively. Total opioid use was recorded several times over a 72‐hr period while self‐reported pain intensity scores were collected multiple times until hospital discharge. Analyses were carried out using growth mixture modelling, logistic regression and general linear models.ResultsBoth pain intensity and opioid consumption showed that a four‐trajectory model best fits the data. Patients in the lowest opioid consumption trajectory were more likely to be classified in the constant mild pain intensity trajectory. Age and baseline levels of anxiety significantly predicted opioid trajectory membership while baseline depressive symptoms significantly predicted pain intensity trajectory membership. Patients in the two highest opioid consumption trajectories reported significantly higher levels of pain catastrophizing at 6 months compared to patients in the other 3 trajectories (all p < 0.05).ConclusionHigh consumption of opioids after surgery is associated with higher levels of pain catastrophizing 6 months later. Identification of patients within these trajectories may lead to the development of early interventions targeted to high risk individuals.SignificanceDifferences in initial levels of opioid consumption and rates of change in opioid consumption shortly after surgery can help predict long‐term psychological responses to pain. Identifying key characteristics associated with initial opioid consumption can lead to the development of cost‐effective early interventions targeted to high risk individuals.
Intensive Care Unit Readmission After Left Ventricular Assist Device Implantation: Causes, Associated Factors, and Association With Patient Mortality
Hui, John C.K., Mauermann, William J., Stulak, John M., Hanson, Andrew C. , Maltais, Simon, Barbara, David W.

Mayo Clinic

Anesthesia & Analgesia | October 9, 2018 | Volume: 128 | Issue: 6 | Pages: 1168-1174

10.1213/ane.0000000000003847 | PMID 31094784 Get It

BACKGROUND: Previous studies on readmissions after left ventricular assist device (LVAD) implantation have focused on hospital readmissions after dismissal from the index hospitalization. Because few data exist, the purpose of this study was to examine intensive care unit (ICU) readmissions in patients during their initial hospitalization for LVAD implantation to determine reasons for, factors associated with, and incidence of mortality after ICU readmission. METHODS: A retrospective analysis was performed from February 2007 to March 2015 of patients at our institution receiving first-time LVAD implantation. After LVAD implantation, patients dismissed from the ICU who then required ICU readmission before hospital dismissal were compared to those not requiring ICU readmission before hospital dismissal with respect to preoperative, intraoperative, and postoperative factors. RESULTS: Among 287 LVAD patients, 266 survived their initial ICU admission, of which 49 (18.4%) required ICU readmission. The most common reasons for readmission were bleeding and respiratory failure. Factors found to be univariably associated with ICU readmission were preoperative hemoglobin, preoperative aspartate aminotransferase, preoperative atrial fibrillation, preoperative dialysis, longer cardiopulmonary bypass times, and higher intraoperative allogeneic blood transfusion requirements. Multivariable analysis revealed ICU readmission to be independently associated with preoperative dialysis (odds ratio, 12.86; 95% confidence interval, 3.16–52.28; P < .001). Overall mortality at 1 year was 22.6%. Survival after hospital dismissal was worse for patients who required ICU readmission during the index hospitalization (adjusted hazard ratio, 2.35; 95% confidence interval, 1.15–4.81; P = .019). CONCLUSIONS: ICU readmission after LVAD implantation occurred relatively frequently and was significantly associated with 1-year mortality after hospital dismissal. These data can perhaps be used to identify subsets of LVAD patients at risk for ICU readmission and may lead to implementation of practice changes to mitigate ICU readmissions. Future larger and prospective studies are warranted.
Salt, water and nephron: Mechanisms of action and link to hypertension and chronic kidney disease
Qian, Qi

Mayo Clinic

Nephrology | October 9, 2018 | Volume: 23 | Issue: S4 | Pages: 44-49

10.1111/nep.13465 | PMID 30298656 Get It

ABSTRACTOur knowledge on sodium and water homeostasis and regulation continues to evolve. A considerable amount of new information in this area has emerged in recent years. This review summarizes existing and new literature and discusses complex multi‐organ effects of high‐salt and low‐water intake and role of arginine vasopressin in this process, as well as the potential clinical significance of non‐osmotic sodium storage pool and rhythmicity of urine sodium excretion. It has become clear that sodium and water dysregulation can exert profound effects on kidney and vascular health, far greater than previously recognized. Maladaptation to a combined high‐salt and low‐water intake can be linked to the growing epidemic of hypertension and chronic kidney disease.
Case of drug reaction with eosinophilia and systemic symptoms secondary to vancomycin
Chamorro-Pareja, Natalia , Patel, Arthi, Youngberg, George A. , Gonzalez‐Estrada, Alexei , Gonzalez-Estrada, Alexei

Mayo Clinic

BMJ Case Reports | October 9, 2018 | Volume: 2018 | Issue: No issue available | Pages: bcr-2018-227378

10.1136/bcr-2018-227378 | PMID 30301733 Get It

Ketolide Treatment of Haemophilus influenzae Experimental Pneumonia
Piper, Kerryl E., Rouse, Mark S., Steckelberg, James M., Wilson, Walter R., Patel, Robin , Patel, Robin

Mayo Clinic

Antimicrobial Agents and Chemotherapy | October 9, 2018 | Volume: 43 | Issue: 3 | Pages: 708-710

10.1128/aac.43.3.708 | PMID 10049297 Get It

ABSTRACT The MICs of HMR 3004 and HMR 3647 at which 90% of beta-lactamase-producing Haemophilus influenzae isolates were inhibited were 4 and 2 μg/ml, respectively. Both HMR 3004 and HMR 3647 were active against beta-lactamase-producing H. influenzae in a murine model of experimental pneumonia. As assessed by pulmonary clearance of H. influenzae , HMR 3004 was more effective ( P < 0.05) than was azithromycin, ciprofloxacin, clarithromycin, erythromycin A, pristinamycin, or HMR 3647 in this model.
Genetic Methods for Assessing Antimicrobial Resistance
Cockerill, Franklin R.

Mayo Clinic

Antimicrobial Agents and Chemotherapy | October 9, 2018 | Volume: 43 | Issue: 2 | Pages: 199-212

10.1128/aac.43.2.199 | PMID 9925507 Get It

DNA Sequence Variation within vanA , vanB , vanC-1 , and vanC-2/3 Genes of Clinical Enterococcus Isol
Patel, Robin , Uhl, J. R., Kohner, Peggy C., Hopkins, Marlene K., Steckelberg, James M., Kline, Bruce C., Cockerill, Franklin R., Patel, Robin

Mayo Clinic

Antimicrobial Agents and Chemotherapy | October 9, 2018 | Volume: 42 | Issue: 1 | Pages: 202-205

10.1128/aac.42.1.202 | PMID 9449290 Get It

ABSTRACT We studied the DNA sequence variation of van genes of 34 isolates of Enterococcus spp. The isolates containing the vanB gene exhibited between 0 and 41 base pair changes per 801 bp studied when the vanB sequences were compared to that of the reference strain Enterococcus faecalis V583. The isolates carrying the vanC-2 gene exhibited between 0 and 23 base pair changes per 346 bp studied when the vanC-2 sequences were compared to that of the reference strain E. casseliflavus ATCC 25788. Little variation was noted in the vanA and vanC-1 genes.
Efficacy of azithromycin or clarithromycin for prophylaxis of viridans group streptococcus experimental endocarditis
Rouse, Mark S., Steckelberg, James M., Brandt, Claudia M., Patel, Robin , Miró, José M., Wilson, Walter R. , Patel, Robin

Mayo Clinic

Antimicrobial Agents and Chemotherapy | October 9, 2018 | Volume: 41 | Issue: 8 | Pages: 1673-1676

10.1128/aac.41.8.1673 | PMID 9257739 Get It

The efficacy of azithromycin or clarithromycin was compared to that of amoxicillin, clindamycin, or erythromycin for the prevention of viridans group streptococcus experimental endocarditis. Rabbits with catheter-induced aortic valve vegetations were given no antibiotics or two doses of amoxicillin at 25 mg/kg of body weight, azithromycin at 10 mg/kg, clarithromycin at 10 mg/kg, clindamycin at 40 mg/kg followed by clindamycin at 20 mg/kg, or erythromycin at 10 mg/kg. Antibiotics were administered 0.5 h before and 5.5 h after intravenous infusion of 5 x 10(5) CFU of Streptococcus milleri. Forty-eight hours after bacterial inoculation, the rabbits were killed and aortic valve vegetations were aseptically removed and cultured for bacteria. Infective endocarditis occurred in 88% of untreated animals, 1% of animals receiving amoxicillin, 9% of animals receiving erythromycin, 0% of animals receiving clindamycin, 2.5% of animals receiving clarithromycin, and 1% of animals receiving azithromycin. All five regimens were more effective (P < 0.001) than no prophylaxis. Erythromycin was less effective (P < 0.05) than amoxicillin or clindamycin. Azithromycin or clarithromycin was as effective as amoxicillin, clindamycin, or erythromycin for the prevention of viridans group streptococcus experimental endocarditis in this model.
Effect of gentamicin dosing interval on efficacy of penicillin or ceftriaxone treatment of experimental endocarditis due to penicillin-susceptible, ceftriaxone-tolerant viridans group streptococci
Brandt, Claudia M., Warner, C B, Rouse, Mark S., Steckelberg, James M., Wilson, Walter R.

Mayo Clinic

Antimicrobial Agents and Chemotherapy | October 9, 2018 | Volume: 40 | Issue: 12 | Pages: 2901-2903

10.1128/aac.40.12.2901 | PMID 9124865 Get It

The efficacy of ceftriaxone or penicillin alone or combined with gentamicin at different dosing intervals was evaluated in experimental endocarditis due to a penicillin-susceptible, ceftriaxone-tolerant strain of Streptococcus sanguis I. The difference between monotherapy with ceftriaxone and procaine penicillin approached statistical significance (P = 0.052). Ceftriaxone combined with gentamicin administered as a single daily dose was less effective than was procaine penicillin combined with gentamicin administered in a single daily dose or in three divided doses.
EUS fine-needle pancreatic core biopsy can determine eligibility for tumor-agnostic immunotherapy
Gleeson, Ferga C. , Levy, Michael J. , Roden, Anja C. , Boardman, Lisa A., Zhang, Lizhi , McWilliams, Robert R. , Boardman, Lisa A., Sinicrope, Frank A.

Mayo Clinic

Endoscopy International Open | October 8, 2018 | Volume: 06 | Issue: 10 | Pages: E1278-E1282

10.1055/a-0650-4447 | PMID 30302387 Get It

Abstract Background and study aims The US FDA recently approved a cancer treatment with pembrolizumab based upon the tumor biomarker status of deficient mismatch repair (dMMR) rather than a specific disease-based approach. We sought to determine if endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) could determine dMMR and quantification of PD-L1 expression to potentially guide the delivery of tumor agnostic immunotherapy. Patients and methods Immunohistochemistry was performed on archived pancreas core biopsy specimens. Tumors with absent nuclear staining of DNA mismatch repair proteins represented dMMR. Tumors were considered to have any or high PD-L1 expression, if expressed in ≥ 1 % or ≥ 50 % of tumor cells. Results Histologic specimen adequacy for MMR status assessment was satisfactory in 97.2 % of tumors. dMMR and high PD-L1 expression was identified in 3 % and 8.1 % of the cohort. Conclusion In the setting of tumor type agnostic immunotherapy, it is projected that at least 3 % of malignant pancreas lesions will be sensitive to pembrolizumab and up to 8 % sensitive to the family of immune checkpoint inhibitors. This highlights the expanding role of EUS-FNB in the field of precision immuno-oncology.